Serum Homocysteine and Paraoxonase1 Levels in Women with Polycystic Ovary Syndrome Treated with Metformin Versus Metformin and Folic Acid

Qusay Mohsin Kadium

Authors

Qusay Mohsin Kadium

patients Besides, increase homocysteine levels significantdecreasein thelevels

Abstract

Background: Polycystic ovary syndrome (PCOS) is the most common reproductive endocrinopathy and currently considered to be a part of the metabolic syndrome. Women with PCOS cluster risk factors associated with risk of atherosclerosis. These risk factors include insulin resistance, dyslipidemia, hyperandrogenemia, obesity, endothelial dysfunction and oxidative stress. homocysteine and paraoxonase 1 in PCOS in two different regimes of treatment with Metformin and Folic acid in order to elucidate some risk factors that may lead to atherosclerosis and vascular diseases in the corresponding patients. Patients and Methods: Fifty patients with PCOS were enrolled in this study that subdivided into two groups according to type of treatment received i.e. G1 (comprising 25 patients) treated with Metformin only, G2 (comprisin25 patients) with Metformin and Folic acid. Serum Homocysteine (Hcy), Paraoxonase 1(PON1) Apolipoprptein A-1(Apo A-1) and Apolipoprotein B(Apo B) were determind by using enzymelinked immunosorbent assay (ELISA). Reduced Glutathion (GSH) and Malondialdehyde (MDA) were determined by using colorimetric method. Results: The results indicated a significant increase in the serum levels of Hcy(p

Downloads

How to Cite

Serum Homocysteine and Paraoxonase1 Levels in Women with Polycystic Ovary Syndrome Treated with Metformin Versus Metformin and Folic Acid. (2013). Global Journal of Science Frontier Research, 13(G2), 35-40. https://www.journalofscience.org/index.php/GJSFR/article/view/993

Download Citation

References

L Nardo, S Patchava, I Laing (2008) Polycystic ovary syndrome: Pathophysiology, molecular aspects and clinical implications. 50(4), 267-278.

J Oates, S Abraham (2010) LIEWELLYN-JONES Fundamentals of obstetrics and gynaecology 9 th edition. 223-224.

B Presannakumari, Sareena Gilvaz (2011) Polycystic Ovarian Syndrome. 140-140.

E Keith (2011) Dewhurst ' s Textbook of Obstetrics and Gynaecology. 517.

C De La, R Usandizga, M Sancha, F Magdaleon, A Herranz, E Carillo (2003) Homocysteine, Folic acid and B-group vitamins in obstetrics and gynecology. 107, 125-134.

Kirsten Holven, Pål Aukrust, Kjetil Retterstøl, Kari Otterdal, Vigdis Bjerkeli, Leiv Ose, Marit Nenseter, Bente Halvorsen (2008) The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects. 138(11), 2070-2075.

D Draganov, J Teiber, A Speelman, Y Osawa, R Sunahara, La Du, B (2005) Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities. 46, 1239-1247.

Joseph Loscalzo (2008) Paraoxonase and Coronary Heart Disease Risk. 1(2), 79-80.

J Zhang, P Fan, H Liu, H Bai1, Wang, F Zhang (2012) Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS. 27(8), 2484-2493.

Y Lee, S Choi, K Lee, D Kim (2011) Apolipoprotein B/A1 ratio is associated with free androgen index and visceral adiposity and may be an indicator of metabolic syndrome in male children and adolescents. 74, 579-586.

T Hiroyuki, K Shintaro, S Matsushima (2011) Oxidative stress and heart failure. 8630-8638.

R Webster, V Roberts, L Myatt (2008) Protein nitration in placenta -functional signifycance. 29, 985-994.

Kaïs Al-Gubory, Paul Fowler, Catherine Garrel (2010) The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. 42(10), 1634-1650.

Dean Eurich, Finlay Mcalister, David Blackburn, Sumit Majumdar, Ross Tsuyuki, Janice Varney, Jeffrey Johnson (2007) Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. 335(7618), 497.

H Lashen (2010) Role of Metformin in the management of polycystic ovary syndrome. 1(3), 117-128.

L Xu, Z Huang, X Xiaoying He, X Wan, D Fang, Y Li (2013) Adverse effect of Metformin therapy on serum vitamin B12 andfolate: Short-term treatment causes disadvantages. 81(2), 149-151.

Signe Altmäe, Anneli Stavreus-Evers, Jonatan Ruiz, Margit Laanpere, Tiina Syvänen, Agneta Yngve, Andres Salumets, Torbjörn Nilsson (2010) Variations in folate pathway genes are associated with unexplained female infertility. 94(1), 130-137.

Y Goh, G Koren (2008) Folic acid in pregnancy and fetal outcomes. 28(1), 3-13.

M Schatchter, A Raziel, S Friedler, D Strassburger, O Orna Bern, R Ron-El (2003) Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. 18(4), 721-727.

Esra Kilicdag, Tayfun Bagis, Ebru Tarim, Erdogan Aslan, Serkan Erkanli, Erhan Simsek, Bulent Haydardedeoglu, Esra Kuscu (2005) Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. 20(6), 1521-1528.

Stefano Palomba, Angela Falbo, Francesco Giallauria, Tiziana Russo, Achille Tolino, Fulvio Zullo, Annamaria Colao, Francesco Orio (2010) Effects of Metformin With or Without Supplementation With Folate on Homocysteine Levels and Vascular Endothelium of Women With Polycystic Ovary Syndrome. 33(2), 246-251.

E Kilicdag, T Bagis, E Tarim, E Aslan, S Erkanli, E Simsek, B Haydardedeoglu, E Kuscu (2005) Homocysteine levels in polycystic ovarian syndrome treated with Metformin versus rosiglitazone. 20(4), 894-899.

Murat Yilmaz, Neslihan Bukan, Göksun Ayvaz, Ayhan Karakoç, Füsun Törüner, Nuri Çakir, Metin Arslan (2005) The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome. 20(12), 3333-3340.

Necat Yilmaz (2012) State of the art paper Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. 1(1), 138-153.

Clifford Bailey (2008) Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes. 22(3), 215-224.

E Nakano, J Higgins, H Powers (2001) Folate protects against oxidative modification of human LDL. 86, 637-639.

E Elia, V Sander, C Luchetti, M Solano, G Girolamo, Di, C Gonzalez, A Motta1 (2006) The mechanisms involved in the action of Metformin in regulating ovarian function in hyperandrogenized mice. 12(8), 475-481.

J Racek, Rusnakova, L Trefil, K Siala (2005) The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. 54, 87-95.